The efficacy of thrombolytic therapy in submassive pulmonary embolism (PE) management is lacking, particularly in specific patient subgroups. The current case report demonstrates the use of catheter-directed thrombolysis (CDT) therapy in conjunction with standard systemic anticoagulation in a patient with sickle cell disease presenting with a submassive PE and chronic thrombus burden. CDT may potentially play a role in the management of submassive PE in sickle cell patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.avsg.2020.08.154 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!